Salukho, V. V., & Ilyinskay, T. A. (2020). New SGLT2 inhibitor ertugliflozin: Safe and effective in the management of type 2 diabetes. Remedium Group LLC.
Chicago Style (17th ed.) CitationSalukho, V. V., and T. A. Ilyinskay. New SGLT2 Inhibitor Ertugliflozin: Safe and Effective in the Management of Type 2 Diabetes. Remedium Group LLC, 2020.
MLA (8th ed.) CitationSalukho, V. V., and T. A. Ilyinskay. New SGLT2 Inhibitor Ertugliflozin: Safe and Effective in the Management of Type 2 Diabetes. Remedium Group LLC, 2020.
Warning: These citations may not always be 100% accurate.